Qandli diabet 2 turini metformin va liraglutid bilan davolashdan keying ichak mikrobiotasidagi o’zgarishlar

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/8904

Full metadata record

DC Field	Value	Language
dc.contributor.author	Shagazatova B.X., Vafoyev Sh.F.	-
dc.date.accessioned	2023-09-06T07:56:44Z	-
dc.date.available	2023-09-06T07:56:44Z	-
dc.date.issued	2023	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/8904	-
dc.description.abstract	Metformin va glyukagonga o'xshash peptid-1 (GPP-1) agonistlari ikkinchi turdagi qandli diabetni (T2DM) davolash uchun keng qo'llaniladi. Yaqinda o'tkazilgan tadqiqotlar ushbu dorilar oshqozon-ichak trakti (OIT) mikrobiotasini o'zgartirishi mumkinligini ko'rsatsada, bu klinik sinovlaridan qo'shimcha tasdiqlash talab etiladi.	en_US
dc.language.iso	other	en_US
dc.publisher	Ўзбекистон, Тошкент	en_US
dc.title	Qandli diabet 2 turini metformin va liraglutid bilan davolashdan keying ichak mikrobiotasidagi o’zgarishlar	en_US
dc.type	Other	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
Сборник_материалов_конференции_Актуальные_проблемы_эндокринологии.pdf	Qandli diabet 2 turini metformin va liraglutid bilan davolashdan keying ichak mikrobiotasidagi o’zgarishlar	2.65 MB	Adobe PDF	View/Open

DSpace JSPUI